Peregrine Pharmaceuticals shares owned by Palisade Capital Management
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Palisade Capital Management
from 13F filings
Historical chart of Palisade Capital Management investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Palisade Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Palisade Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $22M | 2.0M | 11.38 |
| 2024-06-30 | $15M | 2.1M | 7.14 |
| 2024-03-31 | $15M | 2.2M | 6.70 |
| 2023-12-31 | $12M | 1.8M | 6.50 |
| 2023-09-30 | $15M | 1.6M | 9.44 |
| 2023-06-30 | $15M | 1.0M | 13.97 |
| 2023-03-31 | $19M | 1.0M | 18.76 |
| 2022-12-31 | $14M | 990k | 13.77 |
| 2022-09-30 | $18M | 944k | 19.12 |
| 2022-06-30 | $14M | 942k | 15.26 |
| 2022-03-31 | $18M | 858k | 20.37 |
| 2021-12-31 | $28M | 948k | 29.18 |
| 2021-09-30 | $20M | 945k | 21.57 |
| 2021-06-30 | $22M | 869k | 25.65 |
| 2021-03-31 | $16M | 877k | 18.23 |
More positions owned by Palisade Capital Management
View all positions for Palisade Capital Management